- Datum09.05.2025
- Uhrzeit11:00 - 11:30 Uhr
- Veranstalter
XTB
Kein Moderator verfügbar
Veru Inc. Aktie
Verkaufen
Kaufen
Veru Inc. Chart
Veru Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
4,15 %
Intraday
1,58 %
1 Woche
-3,49 %
1 Monat
-19,74 %
Seit Jahresbeginn
-61,89 %
1 Jahr
-93,59 %
3 Jahre
-86,37 %
5 Jahre
-80,81 %
10 Jahre
Passender Service zu Veru Inc.
Webinar zu Veru Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)0,450-1,570
- Jahrestief / Hoch ($)0,450-1,420
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Veru Inc.
Keine Dividenden verfügbar
Termine von Veru Inc.
- Aug7Veru Inc.Q3 2025 Earnings Release
- Feb11Veru Inc.Q1 2026 Earnings Release
Beschreibung
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
